Re-Tolerogen (Toleranzia)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRe-Tolerogen (Toleranzia)
Drug Alias NameTOL-1 (Toleranzia)TolerizeMGMG-tolerogen
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionMuscarinic acetylcholine receptor modulators
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesToleranzia AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToleranzia AB
Active IndicationsN/A
Inactive IndicationsMyasthenia Gravis

Other Information

ATC CodeN/A
Related LinksN/A